medline.ch Onkologie Urologische Tumoren

	Epidemiological profile of kidney cancer in Brazil: a multiregional ecological study. J Bras Nefrol Silva CED, Ciriaco YS, Ribeiro GM, Vidal LA, Cintra VAS, Reis STD. PMID: 40096414 [PubMed - indexed for MEDLINE]
	Pancreatic Serous Neoplasm and Metastatic Clear Cell Renal Cell Carcinoma: Diagnostic Pitfalls Resolvable by a Panel of Immunohistochemical Stains to Include PAX8 and CK7 But Not CAIX. Am J Surg Pathol Theparee T, Umetsu SE, Chan E. PMID: 40096283 [PubMed - indexed for MEDLINE]
	A nomogram based on preoperative NLR predicts distant metastasis of urothelial carcinoma of the bladder. Cancer Biomark Zhang X, Zhang B, He Y, Xiong W, Du Y, Shang P. PMID: 40095506 [PubMed - indexed for MEDLINE]
	Bi-parametric MRI-based quantification radiomics model for the noninvasive prediction of histopathology and biochemical recurrence after prostate cancer surgery: a multicenter study. Abdom Radiol (NY) Wu SY, Wang Y, Fan P, Xu T, Han P, Deng Y, Song Y, Wang X, Zhang M. PMID: 40095016 [PubMed - as supplied by publisher]
	Living Donor Renal Transplant After Ex Vivo Partial Nephrectomy for Incidentally Detected Small Renal Mass: A Case Series. Exp Clin Transplant Joshi BM, Desai P, Dwivedi G, Ranjan S, Kumar A. PMID: 40094253 [PubMed - indexed for MEDLINE]
	The efficacy and safety of (225)Ac-PSMA-617 in metastatic castration-resistant prostate cancer. Front Oncol Ma J, Zhang Y, Yangqing J, Liu G, Wang J, Zhang C. PMID: 40094004 [PubMed]
	Deep learning-based model for prediction of early recurrence and therapy response on whole slide images in non-muscle-invasive bladder cancer: a retrospective, multicentre study. EClinicalMedicine Jiang F, Hong G, Zeng H, Lin Z, Liu Y, Xu A, Shen R, Xie Y, Luo Y, Wang Y, Zhu M, Yang H, Wang H, Huang S, Chen R, Lin T, Wu S. PMID: 40093987 [PubMed]
	Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer - a systematic review and meta-analysis. Theranostics Ninatti G, Scilipoti P, Pini C, Barletta F, Longoni M, Gelardi F, Sollini M, Gandaglia G, Sathekge M, Montorsi F, Chiti A, Briganti A. PMID: 40093902 [PubMed - indexed for MEDLINE]
	Systematic Review of Robotic Nephrectomy for Kidney Cancer. J Kidney Cancer VHL Coco D, Leanza S, Viola MG, Coco D. PMID: 40092607 [PubMed]
	Efficacy and safety of Solifenacin combined with Mirabegron in treating overactive bladder in female patients following bladder instillation for bladder cancer. Am J Transl Res Zhang L, Chen Y, Liao H. PMID: 40092090 [PubMed]
	Recent Advances in Immunotherapy for Bladder Cancer Treatment. Cureus Alqarni KA. PMID: 40091960 [PubMed]
	A Case-Control Study of Association Between Serum Levels of 19 Trace Elements with Prostate Cancer in Southwest China. Biol Trace Elem Res Zhan M, Chuai Y, Zhou X, Li J, Zhou X, Zhang Z, Jin Y, Huang W, Huang X, He S, Zeng H, Qiu S, Zou X. PMID: 40091096 [PubMed - as supplied by publisher]
	Prediction of prostate biopsy outcomes at different cut-offs of prostate-specific antigen using machine learning: a multicenter study. J Egypt Natl Canc Inst Arafa MA, Farhat KH, Aly SF, Khan FK, Mokhtar A, Althunayan AM, Al-Taweel W, Al-Khateeb SS, Azhari S, Rabah DM. PMID: 40090974 [PubMed - indexed for MEDLINE]
	Treatment of Metastatic Renal Cell Carcinoma: Lack of Consensus Urges the Need for a Well-organized Multidisciplinary Team. Eur Urol Oncol Muselaers S, Heng D, Ciccarese C, Siva S. PMID: 40090835 [PubMed - as supplied by publisher]
	Exosome biosensors for detection of prostate cancer. Clin Chim Acta Vafadar A, AlaviManesh S, Maddahi ME, Alizadeh M, Movahedpour A, Savardashtaki A. PMID: 40090566 [PubMed - as supplied by publisher]
	Diagnostic image-based treatment planning for online adaptive ultra-hypofractionated prostate cancer radiotherapy with MR-Linac. J Appl Clin Med Phys Xu Y, Lu N, Li Q, Men K, Zhao X, Dai J. PMID: 40089971 [PubMed - as supplied by publisher]
	Current androgen receptor antagonists under investigation for resistant prostate cancer: progress and challenges. Expert Rev Anticancer Ther Danielli L, Tassinari E, Marchetti A, Rosellini M, Mollica V, Cheng L, Massari F. PMID: 40089934 [PubMed - as supplied by publisher]
	Empowering PARP inhibition through rational combination: Mechanisms of PARP inhibitors and combinations with a focus on the treatment of metastatic castration-resistant prostate cancer. Crit Rev Oncol Hematol Zhao J, Tang B, Shen P, Zeng H, Wei Q. PMID: 40089046 [PubMed - as supplied by publisher]
	High-fidelity telomerase activity assay based on light-triggered nucleic acid separation system for the diagnosis of bladder cancer. Biosens Bioelectron Cheng M, Zhang L, Han X, Xu H, Shi H, Lin Y. PMID: 40088701 [PubMed - as supplied by publisher]
	Local therapy for oligometastatic prostate cancer. Jpn J Clin Oncol Kawai T, Taguchi S, Nakagawa T, Kume H. PMID: 40088427 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 165758

Seite 1 von 8288

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung